One inhaler to rule them all? new asthma study for kids

NCT ID NCT06429475

Recruiting now Disease control Sponsor: University of KwaZulu Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether using one inhaler (budesonide/formoterol) for both quick relief and daily control can reduce asthma attacks in children ages 6-18 in South Africa. About 1,038 kids with asthma will be split into two groups: one gets the single inhaler, the other gets separate inhalers for relief and control. The study lasts 52 weeks and tracks how many asthma attacks each group has.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ASTHMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

asthma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ASTHMA

Contacts and locations

Locations

Africa Research Health Institute Clinical Trial Unit
RECRUITING

Mtubatuba, KwaZulu-Natal, 3935, South Africa
Africa Research Health Institute Clinical Trial Unit
RECRUITING

Mtubatuba, KwaZulu-Natal, 3965, South Africa

More trials for these conditions

Other studies related to the condition(s) this trial covers.